Literature DB >> 8549394

Causative organisms in acute exacerbation of chronic airways disease and response to ofloxacin therapy.

A W Sufarlan1, B M Zainudin, S Pit, I Ishak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549394     DOI: 10.2165/00003495-199500492-00129

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  10 in total

1.  Bacteriologic diagnosis of acute pneumonia. Comparison of sputum, transtracheal aspirates, and lung aspirates.

Authors:  M Davidson; B Tempest; D L Palmer
Journal:  JAMA       Date:  1976-01-12       Impact factor: 56.272

2.  Priorities in biomedical research. Indices of burden.

Authors:  D A Black; J D Pole
Journal:  Br J Prev Soc Med       Date:  1975-12

3.  The diagnostic value of sputum culture in acute pneumonia.

Authors:  S B Thorsteinsson; D M Musher; T Fagan
Journal:  JAMA       Date:  1975-08-25       Impact factor: 56.272

Review 4.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

5.  Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates.

Authors:  J G Bartlett; S M Finegold
Journal:  Am Rev Respir Dis       Date:  1978-06

6.  The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia.

Authors:  E Barrett-Connor
Journal:  Am Rev Respir Dis       Date:  1971-06

7.  Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study.

Authors:  C Grassi; G Gialdroni Grassi; P Mangiarotti
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  New notions in chronic bronchitis and emphysema.

Authors:  D C Flenley
Journal:  Practitioner       Date:  1983-11

9.  A prospective study of ofloxacin in acute exacerbations of chronic respiratory disease associated with Pseudomonas aeruginosa.

Authors:  J C Meek; F P Maesen; B I Davies
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

10.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.